Cash conversion remains robust with an OCF/NI ratio of 1.11, while capital expenditure intensity has moderated to 3.7% of revenue.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 |
|---|
| Cash from Operations | 3.36B | 3.03B | 2.42B | 1.81B | 1.49B | 2.09B | 1.48B | 1.6B | 1.17B | 1.14B | 1.04B | 771.9M | 665.1M | 880M | 814.2M | 677.6M | 528M | 385.06M | 278.24M | 205.69M | 99.84M | 70.79M | 30.32M | -7.85M | -14.15M | -18.55M | -12.8M | -15.93M |
| Operating CF Margin % | - | 30.11% | 28.91% | 25.46% | 23.96% | 36.59% | 34.07% | 35.69% | 31.41% | 36.56% | 38.56% | 32.37% | 31.2% | 38.85% | 37.37% | 38.56% | 37.37% | 36.6% | 31.8% | 34.23% | 26.79% | 31.14% | 21.84% | -8.57% | -19.64% | -35.9% | -48.09% | -156.27% |
| Operating CF Growth % | 99.62% | 25.49% | 33.15% | 21.67% | -28.65% | 40.72% | -7.1% | 36.65% | 2.25% | 9.68% | 35.11% | 16.06% | -24.42% | 8.08% | 20.16% | 28.33% | 37.12% | 38.39% | 35.27% | 106.01% | 41.05% | 133.5% | 485.98% | 44.49% | 23.74% | -44.9% | 19.61% | - |
| Net Income | 2.98B | 2.88B | 2.34B | 1.82B | 1.34B | 1.73B | 1.07B | 1.38B | 1.13B | 660M | 735.9M | 588.8M | 418.8M | 671M | 656.6M | 495.1M | 381.8M | 232.61M | 204.31M | 144.54M | 72.04M | 94.13M | 23.48M | -9.62M | -18.42M | -16.7M | -18.52M | -18.41M |
| Depreciation & Amortization | 736.2M | 677.1M | 462M | 435.2M | 365.8M | 310.2M | 276.2M | 203M | 122.8M | 99.1M | 92.1M | 89.5M | 74.4M | 67.3M | 57.8M | 46.5M | 40.4M | 34.58M | 25.08M | 13.03M | 35.27M | 6.73M | 7.11M | 10.63M | 4.55M | 4.71M | 4.75M | 2.24M |
| Stock-Based Compensation | 812.5M | 788.2M | 676.8M | 598.2M | 513.2M | 449.2M | 395.4M | 335.8M | 261.2M | 209.1M | 177.6M | 167.9M | 168.9M | 168.9M | 153.3M | 136.4M | 117.6M | 96.98M | 0 | 36.29M | 25.26M | 4.75M | 0 | 700K | 2.57M | 0 | 0 | 0 |
| Deferred Taxes | 358.3M | 19.1M | -135.3M | -280.8M | -185.3M | -62.6M | 57.6M | -8M | 31.9M | 62.9M | 18.7M | 4.6M | -35M | -38.5M | -20.8M | 7.1M | -21.5M | -15.64M | -20.5M | 3.91M | 9.08M | -40.76M | 0 | -700K | -2.57M | 0 | 0 | 0 |
| Other Non-Cash Items | -1.73B | -58.2M | -6.7M | 21.5M | 71.8M | 32.6M | -38M | 7.1M | 12.4M | 21.2M | 21.6M | 13.6M | 23.8M | 33.3M | 32.8M | 12.4M | -7.3M | -1.5M | 79.27M | 5.95M | -13.63M | 15.71M | 283K | 892K | 66K | -87K | 0 | 150K |
| Working Capital Changes | 190.9M | -1.27B | -919.3M | -777.6M | -619.1M | -368.1M | -273.2M | -321.5M | -383.7M | 91.6M | -3M | -92.5M | 14.2M | -22M | -65.5M | -19.9M | 17M | 38.03M | -9.94M | 1.97M | -28.18M | -9.78M | -557K | -9.75M | -342K | -6.48M | 967K | 95K |
| Change in Receivables | -280.2M | -301.7M | -95.9M | -186.3M | -159.3M | -142.3M | 5.7M | 38.8M | -161.3M | -81.7M | -35.9M | -79.2M | -13.7M | 68.9M | -68.9M | -51.1M | -41.5M | -35.27M | 0 | -35.69M | -41.85M | -17.46M | 0 | -6.35M | -4.4M | 0 | 0 | 0 |
| Change in Inventory | -1.12B | -1.06B | -830M | -712.5M | -546.6M | -256M | -170.1M | -360.5M | -279M | -115.5M | -46.7M | -10.7M | -26.8M | -70M | -7.1M | -25.3M | -29.2M | 5.86M | -31.06M | -8.21M | -9.02M | -9.21M | 2.82M | 4.62M | -2.56M | -106K | -3.21M | -1.6M |
| Change in Payables | 48.7M | 57.9M | -400K | 41.7M | 21.3M | 36M | -32.3M | 12.3M | 16.7M | 14M | 15.9M | -11.3M | 17.7M | -8.9M | 8.4M | 10.3M | 8.1M | 7.04M | 0 | 18.65M | 3.11M | 3.5M | 0 | -4.78M | 4.41M | 0 | 0 | 0 |
| Cash from Investing | -462.2M | 665.8M | -3.27B | -360.1M | 1.37B | -2.46B | -940.6M | -1.15B | -1.05B | 378.7M | -1.28B | -849.5M | -153.9M | 259M | -845.7M | -479M | -476.5M | -292.38M | -304.53M | -236.4M | -113.35M | -103.31M | -48.15M | -71.18M | 18.17M | 5.61M | -50.82M | -10.31M |
| Capital Expenditures | -526.5M | -539.8M | -1.11B | -1.06B | -532.4M | -353.5M | -341.5M | -425.6M | -187.4M | -190.7M | -53.9M | -81M | -105.6M | -104.6M | -141.8M | -82.9M | -96M | -53.42M | -105.97M | -24.01M | -18.05M | -30.05M | -22.44M | -2.52M | -5.79M | -5.53M | -3.56M | -931K |
| CapEx % of Revenue | 4.98% | 5.36% | 13.3% | 14.94% | 8.56% | 6.19% | 7.84% | 9.5% | 5.03% | 6.09% | 1.99% | 3.4% | 4.95% | 4.62% | 6.51% | 4.72% | 6.79% | 5.08% | 12.11% | 4% | 4.84% | 13.22% | 16.17% | 2.75% | 8.04% | 10.7% | 13.35% | 9.13% |
| Acquisitions | -12.7M | -13.9M | -1M | -8.9M | -12.8M | -8.7M | -37.7M | -59.7M | -87.9M | 190.7M | 53.9M | 81M | -84.3M | 104.6M | 141.8M | 0 | 0 | 0 | 304.53M | 19.93M | 18.05M | 10K | 0 | -8.46M | -40K | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -483.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -774.3M | -190.7M | -53.9M | -81M | 36M | -104.6M | -141.8M | 0 | 0 | 0 | -304.53M | -19.93M | -18.05M | -1.17M | 306K | 275K | 62K | 36K | -3M | 0 |
| Cash from Financing | -3.48B | -2.36B | 150.9M | -287.6M | -2.57B | 43M | -85.7M | -168.4M | 126.3M | -1.91B | 558.5M | 193.4M | -692.4M | -910.6M | 119.2M | -12.4M | 7.7M | -66.17M | 97.98M | 118.85M | 42.18M | 32.32M | 12.12M | 82.33M | 3M | 771K | 82.17M | 20.18M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -608K | -1.12M | -1.62M | 947K | -1.48M | -259K | 822K |
| Equity Issued (Net) | -2.08B | -1.95B | 429.4M | -416.3M | -2.37B | 276.5M | 174.5M | -269.5M | 236.6M | -1.86B | 538.4M | 177.4M | -716.4M | -948.6M | 25M | -71.2M | -57.5M | -91.31M | 44.68M | 55.98M | 19.14M | 32.92M | 13.23M | 83.96M | 2.06M | 2.25M | 82.43M | 19.36M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -3.42B | -2.3B | 0 | -416.3M | -2.61B | 0 | -134.3M | -269.5M | 0 | -2.27B | -42.5M | -183.7M | -1B | -1.11B | -238.3M | -331.8M | -198.6M | -150M | 0 | 0 | 0 | -72K | 0 | -6K | -2K | -65K | -20K | -43K |
| Other Financing | -1.4B | -419.1M | -278.5M | 128.7M | -198.7M | -233.5M | -260.2M | 101.1M | -110.3M | -54.6M | 20.1M | 16M | 24M | 38M | 94.2M | 58.8M | 65.2M | 25.14M | 53.3M | 62.87M | 23.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -561.6M | 1.34B | -707.7M | 1.17B | 294.7M | -332.5M | 455.9M | 273.2M | 246.2M | -388.4M | 322M | 114.3M | -181.8M | 228.4M | 87.9M | 186M | 58.4M | 26.81M | 71.8M | 88.44M | 28.88M | -263K | -5.56M | 3.28M | 7.12M | -12.17M | 18.55M | -6.06M |
| Free Cash Flow | 2.83B | 2.49B | 1.3B | 749.6M | 958.4M | 1.74B | 1.14B | 1.17B | 982.2M | 953.2M | 989M | 690.9M | 559.5M | 775.4M | 672.4M | 594.7M | 432M | 331.64M | 172.26M | 181.68M | 81.79M | 40.73M | 7.88M | -10.38M | -19.94M | -24.08M | -16.36M | -16.86M |
| FCF Margin % | 26.78% | 24.75% | 15.61% | 10.52% | 15.4% | 30.4% | 26.23% | 26.18% | 26.37% | 30.46% | 36.57% | 28.98% | 26.25% | 34.23% | 30.86% | 33.84% | 30.57% | 31.52% | 19.69% | 30.24% | 21.95% | 17.92% | 5.67% | -11.32% | -27.68% | -46.6% | -61.44% | -165.4% |
| FCF Growth % | 62.4% | 91.03% | 73.93% | -21.79% | -44.79% | 51.83% | -2.5% | 19.39% | 3.04% | -3.62% | 43.15% | 23.49% | -27.84% | 15.32% | 13.07% | 37.66% | 30.26% | 92.52% | -5.18% | 122.13% | 100.8% | 417.18% | 175.88% | 47.94% | 17.21% | -47.2% | 2.96% | - |
| FCF per Share | 7.88 | 6.87 | 3.60 | 2.10 | 2.65 | 4.75 | 3.17 | 3.27 | 2.76 | 2.73 | 2.80 | 2.03 | 1.65 | 2.15 | 1.82 | 1.64 | 1.19 | 0.94 | 0.48 | 0.52 | 0.24 | 0.12 | 0.03 | -0.05 | -0.12 | -0.15 | -0.15 | -0.77 |
| FCF Conversion (FCF/Net Income) | 0.95x | 1.06x | 1.04x | 1.01x | 1.13x | 1.23x | 1.40x | 1.16x | 1.04x | 1.73x | 1.42x | 1.31x | 1.59x | 1.31x | 1.24x | 1.37x | 1.38x | 1.66x | 1.36x | 1.42x | 1.39x | 0.75x | 1.29x | 0.82x | 0.77x | 1.11x | 0.69x | 0.86x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 537.9M | 466.5M | 447.8M | 444.2M | 0 | 0 | 0 | 179.2M | 147.5M | 138.4M | 110.3M | 176.8M | 194.1M | 226.1M | 152M | 124.4M | 129.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital expenditure cycle volatility
As reported in recent financial statements, ISRG has demonstrated a significant improvement in cash conversion, with the OCF/NI ratio reaching 1.11 in 2026Q1, suggesting that the company is effectively translating its accounting profits into tangible cash inflows despite rising stock-based compensation expenses.
The consistent alignment between net income and operating cash flow indicates a high quality of earnings, largely devoid of aggressive accrual accounting. Investors should monitor whether this conversion efficiency persists as the company scales its newer platform iterations, which may carry different working capital requirements.
Based on the provided quarterly data, ISRG's free cash flow margin has recovered to 29.2% in 2026Q1, marking a substantial turnaround from the negative margins observed in 2023Q4 and reflecting the successful maturation of the company's recurring revenue model and disciplined cost management.
The trajectory of free cash flow suggests that the business is moving past the peak investment phase associated with recent product launches. This trend implies that the company is increasingly capable of self-funding its R&D initiatives while simultaneously generating excess liquidity for capital return programs.
According to historical filings, ISRG's capital expenditure as a percentage of revenue has moderated to 3.7% in 2026Q1, down from a peak of 22.6% in 2023Q4, indicating a transition toward a more efficient capital deployment phase following recent infrastructure and manufacturing capacity investments.
The reduction in capital intensity suggests that the company has largely completed the necessary heavy lifting for its current manufacturing footprint. This shift warrants further investigation into whether future capex will remain at these lower levels or if upcoming technological cycles will necessitate another period of elevated spending.
As evidenced by recent cash flow statements, ISRG has utilized its robust cash generation to execute significant share repurchases, including $1.1 billion in 2026Q1, signaling management's confidence in the long-term value of the firm despite the absence of a formal dividend policy.
The aggressive use of cash for buybacks, rather than large-scale acquisitions, highlights a preference for returning capital to shareholders while maintaining a fortress balance sheet. This strategy appears to prioritize internal growth and share count reduction, which may support EPS growth in the absence of transformative M&A.
Quick answers to the most common questions about buying ISRG stock.
Intuitive Surgical, Inc. (ISRG) generated $3.03B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Intuitive Surgical, Inc. (ISRG) generated $2.49B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Intuitive Surgical, Inc. (ISRG) spent $539.8M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Intuitive Surgical, Inc. (ISRG) spent $2.30B on share repurchases. This shows the company's commitment to returning capital to its equity investors.